EMEIS SA(EPA:EMEIS) stock Fundamental Analysis

Fundamental Rating

EMEIS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 25 industry peers in the Health Care Providers & Services industry. While EMEIS is still in line with the averages on profitability rating, there are concerns on its financial health. EMEIS is not priced too expensively while it is growing strongly. Keep and eye on this one!

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EMEIS was profitable.

EMEIS had a positive operating cash flow in the past year.

Of the past 5 years EMEIS 4 years were profitable.

In the past 5 years EMEIS always reported a positive cash flow from operatings.

1.2 Ratios

EMEIS has a Return On Assets of 9.74%. This is amongst the best in the industry. EMEIS outperforms 100.00% of its industry peers.

EMEIS has a better Return On Equity (71.82%) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	9.74%
ROE	71.82%
ROIC	N/A

ROA(3y)-5.89%

ROA(5y)-3.02%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of EMEIS (26.07%) is better than 100.00% of its industry peers.

EMEIS's Profit Margin has improved in the last couple of years.

EMEIS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	26.07%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y85.55%

PM growth 5Y32.24%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EMEIS does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for EMEIS has been reduced compared to 1 year ago.

EMEIS has less shares outstanding than it did 5 years ago.

EMEIS has a better debt/assets ratio than last year.

2.2 Solvency

EMEIS has an Altman-Z score of 0.35. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.35, EMEIS is not doing good in the industry: 79.17% of the companies in the same industry are doing better.

EMEIS has a Debt/Equity ratio of 4.30. This is a high value indicating a heavy dependency on external financing.

EMEIS has a Debt to Equity ratio of 4.30. This is amonst the worse of the industry: EMEIS underperforms 87.50% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	4.3
Debt/FCF	N/A
Altman-Z	0.35

ROIC/WACCN/A

WACC4.48%

2.3 Liquidity

EMEIS has a Current Ratio of 0.60. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.60, EMEIS is not doing good in the industry: 79.17% of the companies in the same industry are doing better.

A Quick Ratio of 0.60 indicates that EMEIS may have some problems paying its short term obligations.

EMEIS has a Quick ratio of 0.60. This is in the lower half of the industry: EMEIS underperforms 62.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.6
Quick Ratio	0.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EMEIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 256.77%, which is quite impressive.

The Earnings Per Share has been growing by 116.08% on average over the past years. This is a very strong growth

The Revenue has grown by 11.04% in the past year. This is quite good.

The Revenue has been growing by 8.73% on average over the past years. This is quite good.

EPS 1Y (TTM)256.77%

EPS 3Y301.6%

EPS 5Y116.08%

EPS Q2Q%278.1%

Revenue 1Y (TTM)11.04%

Revenue growth 3Y9.84%

Revenue growth 5Y8.73%

Sales Q2Q%11.4%

3.2 Future

Based on estimates for the next years, EMEIS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.92% on average per year.

The Revenue is expected to grow by 8.12% on average over the next years. This is quite good.

EPS Next Y98.51%

EPS Next 2Y41.41%

EPS Next 3Y25.92%

EPS Next 5YN/A

Revenue Next Year7.81%

Revenue Next 2Y9.12%

Revenue Next 3Y8.12%

Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EMEIS is valuated cheaply with a Price/Earnings ratio of 1.07.

EMEIS's Price/Earnings ratio is rather cheap when compared to the industry. EMEIS is cheaper than 100.00% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 28.47. EMEIS is valued rather cheaply when compared to this.

The Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	1.07
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

EMEIS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as EMEIS's earnings are expected to grow with 25.92% in the coming years.

PEG (NY)0.01

PEG (5Y)0.01

EPS Next 2Y41.41%

EPS Next 3Y25.92%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EMEIS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EMEIS SA

EPA:EMEIS (2/5/2025, 12:31:01 PM)

6.68

-0.08 (-1.26%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)01-16 2025-01-16/amc

Earnings (Next)N/A N/A

Inst Owners54.52%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.08B

Analysts44.44

Price Target11.63 (74.1%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-15.56%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-166.44%

EPS NY rev (3m)-70.43%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)3.32%

Revenue NY rev (3m)3.32%

Valuation

		Industry Rank	Sector Rank
PE	1.07
Fwd PE	N/A
P/S	0.21
P/FCF	N/A
P/OCF	2.94
P/B	0.57
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)6.26

EY93.71%

EPS(NY)-1.91

Fwd EYN/A

FCF(TTM)-0.56

FCFYN/A

OCF(TTM)2.27

OCFY34.03%

SpS32.27

BVpS11.71

TBVpS-6.28

PEG (NY)0.01

PEG (5Y)0.01

Profitability

		Industry Rank	Sector Rank
ROA	9.74%
ROE	71.82%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	26.07%
GM	N/A
FCFM	N/A

ROA(3y)-5.89%

ROA(5y)-3.02%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y85.55%

PM growth 5Y32.24%

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	4.3
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	8.78%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.6
Quick Ratio	0.6
Altman-Z	0.35

F-Score6

WACC4.48%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)13.91%

Cap/Sales(5y)16.01%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)256.77%

EPS 3Y301.6%

EPS 5Y116.08%

EPS Q2Q%278.1%

EPS Next Y98.51%

EPS Next 2Y41.41%

EPS Next 3Y25.92%

EPS Next 5YN/A

Revenue 1Y (TTM)11.04%

Revenue growth 3Y9.84%

Revenue growth 5Y8.73%

Sales Q2Q%11.4%

Revenue Next Year7.81%

Revenue Next 2Y9.12%

Revenue Next 3Y8.12%

Revenue Next 5YN/A

EBIT growth 1Y81.83%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year124.45%

EBIT Next 3Y31.64%

EBIT Next 5YN/A

FCF growth 1Y-135.95%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-10.64%

OCF growth 3Y-22.21%

OCF growth 5Y-2.48%

EMEIS SA (EMEIS.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens